Castrodale Louisa
Alaska Section of Epidemiology, Anchorage, AK 99503, USA.
Public Health Rep. 2009 Mar-Apr;124(2):262-6. doi: 10.1177/003335490912400214.
The aim of this study was to summarize the Alaska experience in centralizing distribution of rabies postexposure prophylaxis (PEP).
Data were collected from standard treatment sheets used to track doses and notes related to the exposure investigations.
From 2002 to 2007, the annual PEP usage rate was 2.2 per 100,000. Dogs were involved in 79% (68/86) of exposures. More than 50% (49/87) of people were exposed to a confirmed rabid animal; 31 (63%) of those people experienced nonbite exposures. Conversely, of the remaining 38 people exposed to an animal for which rabies status could not be confirmed, 35 (92%) sustained a bite or puncture. Direct and indirect costs averaged more than $3000 per person.
The Alaska PEP usage rate was lower and the proportion of people exposed to confirmed rabid animals was higher when compared with other states. Alaska public health personnel invested significant time to ensure that PEP was only given when indicated. Without this gatekeeper approach, PEP would likely be administered at a much higher rate because medical facility staff lacks the time or ability to investigate animal exposures to rule out rabies. In Alaska, centralizing rabies PEP not only serves the patient's best interest, but it also makes efficient use of a potentially scarce product and supports rabies surveillance efforts by guaranteeing animals for testing. Such a program might not be feasible for a more populous state or jurisdiction, or areas with different rabies epizootiology; however, that may change if the supply of rabies biologics changes in the future.
本研究旨在总结阿拉斯加在集中分发狂犬病暴露后预防(PEP)方面的经验。
从用于追踪剂量及与暴露调查相关记录的标准治疗表中收集数据。
2002年至2007年,PEP的年使用率为每10万人2.2例。79%(68/86)的暴露事件涉及犬类。超过50%(49/87)的人接触过确诊患有狂犬病的动物;其中31人(63%)经历了非咬伤暴露。相反,在其余38名接触过狂犬病状态无法确认的动物的人中,35人(92%)遭受了咬伤或刺伤。直接和间接成本平均每人超过3000美元。
与其他州相比,阿拉斯加的PEP使用率较低,而接触确诊患有狂犬病动物的人群比例较高。阿拉斯加的公共卫生人员投入了大量时间,以确保仅在有指征时才给予PEP。如果没有这种把关方法,PEP的给药率可能会高得多,因为医疗机构工作人员没有时间或能力调查动物暴露情况以排除狂犬病。在阿拉斯加,集中管理狂犬病PEP不仅符合患者的最大利益,还能有效利用可能稀缺的产品,并通过保证提供用于检测的动物来支持狂犬病监测工作。这样的项目对于人口更多的州或管辖区,或狂犬病流行情况不同的地区可能不可行;然而,如果未来狂犬病生物制品的供应发生变化,情况可能会有所改变。